06/19/2018 – RespireRx Pharmaceuticals Inc. Advancing Dronabinol Obstructive Sleep Apnea Program with Letter of Intent for Co-Development and Supply Agreement with Noramco, Inc. June 19, 2018j3ff1 Read More
RespireRx Pharmaceuticals Inc. to Present at 10th Annual Biotech Showcase 2018 January 8, 2018j3ff1 Read More
RespireRx Pharmaceuticals Publishes Scientific Evidence Demonstrating CX717 Neurobiological Safety December 18, 2017j3ff1 Read More
RespireRx Presentation at 2017 Rodman & Renshaw Conference on 09/12/17 September 8, 2017j3ff1 Read More
RespireRx Pharmaceuticals Inc. to Present at 2017 Rodman & Renshaw Conference September 8, 2017j3ff1 Read More
RespireRx Pharmaceuticals Inc. Files June 30, 2017 Quarterly Report on Form 10-Q And Provides Update August 25, 2017j3ff1 Read More
